Canopy Growth Corporation
CGC · NASDAQ
Bulios Fair Price
$0.85
9.4% downside
Current Price
$0.94
According to Bulios Fair Price, CGC is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Canopy Growth Corporation (CGC) is one of the leading global producers and retailers of legal medical cannabis and related products. The company operates in various areas of the cannabis industry, including cultivation, processing, research, and the development of new products. Canopy Growth has its own brands offering a wide range of cannabinoid-containing products, including CBD and THC. The company also has strategic partnerships with pharmaceutical companies and invests in innovative cannabis-related projects. With its global reach and expansion into new markets, Canopy Growth holds a solid position in the cannabis market. Investing in Canopy Growth Corporation (CGC) shares can be an interesting choice for investors who follow the medical cannabis sector and seek a company with potential for growth in the growing industry.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Luc Mongeau
Employees
1,128
Headquarters
Smiths Falls
Upcoming events
Earnings
Upcoming earnings report